ResMed Inc. Forecasted to Earn Q2 2025 Earnings of $2.10 Per

ResMed Inc. (NYSE:RMD – Free Report) – Investment analysts at Zacks Research lifted their Q2 2025 earnings estimates for ResMed in a research report issued to clients and investors on Monday, May 27th. Zacks Research analyst R. Department now expects that the medical equipment provider will post earnings per share of $2.10 for the quarter, […]

Related Keywords

Canada , Hall Laurie , Michaelj Farrell , Zacks Research , Resmed Inc , Financial Private Wealth Inc , Royal Bank , Solutions Inc , Operose Advisors , Atlantic Edge Private Wealth Management , Securities Exchange Commission , Keycorp , Needham Company , Hr Department , Free Report , Get Free Report , Exchange Commission , Edge Private Wealth Management , Lauriej Trustee , Private Wealth , Med Inc , Respiratory Care , Resmed Daily ,